Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitsuhiro Akiyama

Showing results (41-50 of 97) with videos related to

Pageof 10
Sort By:
Internal Medicine (Tokyo, Japan)|March 3, 2024
Successful Treatment of Rosai-Dorfman Disease with Cutaneous Involvement and Arthritis with Methotrexate and InfliximabKoji Suzuki, Mitsuhiro Akiyama, Yasushi Kondo, et al.
The Journal of Rheumatology|September 1, 2024
Performance of the 2022 ACR/EULAR Classification Criteria in Comparison With the European Medicines Agency Algorithm in Antineutrophil Cytoplasmic Antibody-Associated VasculitisYuki Imai, Yuichiro Ota, Kotaro Matsumoto, et al.
Rheumatology (Oxford, England)|May 2, 2017
Follicular helper T cells in the pathogenesis of IgG4-related diseaseMitsuhiro Akiyama, Katsuya Suzuki, Hidekata Yasuoka, et al.
Frontiers in Immunology|May 3, 2021
Peripheral TIGIT+ T Follicular Helper Cells That Produce High Levels of Interleukin-21 <i>via</i> OX40 Represent Disease Activity in IgG4-Related DiseaseMitsuhiro Akiyama, Katsuya Suzuki, Keiko Yoshimoto, et al.
Rheumatology (Oxford, England)|July 8, 2022
Disease-specific expansion of CD29+IL-17RA+ T effector cells possessing multiple signalling pathways in spondyloarthritisMitsuhiro Akiyama, Keiko Yoshimoto, Sho Ishigaki, et al.
Autoimmunity Reviews|June 17, 2025
Clinical features, pathogenesis, and treatment of inflammatory bowel disease-associated spondyloarthritisMitsuhiro Akiyama, Waleed Alshehri, Koji Suzuki, et al.
Rheumatology International|October 9, 2024
Successful treatment of Crohn's disease-related peripheral spondyloarthritis with upadacitinib: two case reports and case-based reviewKoji Suzuki, Mitsuhiro Akiyama, Hajime Inokuchi, et al.
Internal Medicine (Tokyo, Japan)|March 3, 2024
Successful Immunosuppressive Therapy for Interstitial Lung Disease Associated with Sjögren's Syndrome with Double-positive Anti-SS-A and Anti-centromere AntibodiesKoji Suzuki, Mitsuhiro Akiyama, Yasushi Kondo, et al.
Clinical and Experimental Rheumatology|February 22, 2018
Serum soluble interleukin-2 receptor is a useful biomarker for disease activity but not for differential diagnosis in IgG4-related disease and primary Sjögren's syndrome adults from a defined populationMitsuhiro Akiyama, Takanori Sasaki, Yuko Kaneko, et al.
Clinical and Experimental Rheumatology|December 3, 2024
CCR4+Tfh2 cells specifically produce IL-4 driving the pathological reaction in IgG4-related diseaseMitsuhiro Akiyama, Keiko Yoshimoto, Hidekata Yasuoka, et al.
Pageof 10

Showing results (41-50 of 97) with videos related to

Sort By:
Pageof 10
Internal Medicine (Tokyo, Japan)|March 3, 2024
Successful Treatment of Rosai-Dorfman Disease with Cutaneous Involvement and Arthritis with Methotrexate and InfliximabKoji Suzuki, Mitsuhiro Akiyama, Yasushi Kondo, et al.
The Journal of Rheumatology|September 1, 2024
Performance of the 2022 ACR/EULAR Classification Criteria in Comparison With the European Medicines Agency Algorithm in Antineutrophil Cytoplasmic Antibody-Associated VasculitisYuki Imai, Yuichiro Ota, Kotaro Matsumoto, et al.
Rheumatology (Oxford, England)|May 2, 2017
Follicular helper T cells in the pathogenesis of IgG4-related diseaseMitsuhiro Akiyama, Katsuya Suzuki, Hidekata Yasuoka, et al.
Frontiers in Immunology|May 3, 2021
Peripheral TIGIT+ T Follicular Helper Cells That Produce High Levels of Interleukin-21 <i>via</i> OX40 Represent Disease Activity in IgG4-Related DiseaseMitsuhiro Akiyama, Katsuya Suzuki, Keiko Yoshimoto, et al.
Rheumatology (Oxford, England)|July 8, 2022
Disease-specific expansion of CD29+IL-17RA+ T effector cells possessing multiple signalling pathways in spondyloarthritisMitsuhiro Akiyama, Keiko Yoshimoto, Sho Ishigaki, et al.
Autoimmunity Reviews|June 17, 2025
Clinical features, pathogenesis, and treatment of inflammatory bowel disease-associated spondyloarthritisMitsuhiro Akiyama, Waleed Alshehri, Koji Suzuki, et al.
Rheumatology International|October 9, 2024
Successful treatment of Crohn's disease-related peripheral spondyloarthritis with upadacitinib: two case reports and case-based reviewKoji Suzuki, Mitsuhiro Akiyama, Hajime Inokuchi, et al.
Internal Medicine (Tokyo, Japan)|March 3, 2024
Successful Immunosuppressive Therapy for Interstitial Lung Disease Associated with Sjögren's Syndrome with Double-positive Anti-SS-A and Anti-centromere AntibodiesKoji Suzuki, Mitsuhiro Akiyama, Yasushi Kondo, et al.
Clinical and Experimental Rheumatology|February 22, 2018
Serum soluble interleukin-2 receptor is a useful biomarker for disease activity but not for differential diagnosis in IgG4-related disease and primary Sjögren's syndrome adults from a defined populationMitsuhiro Akiyama, Takanori Sasaki, Yuko Kaneko, et al.
Clinical and Experimental Rheumatology|December 3, 2024
CCR4+Tfh2 cells specifically produce IL-4 driving the pathological reaction in IgG4-related diseaseMitsuhiro Akiyama, Keiko Yoshimoto, Hidekata Yasuoka, et al.
Pageof 10